Fidelity Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
|
|||||
|
2025
Q1 | $2.62M | Buy |
|
|||||
|
2024
Q4 | $2.02M | Buy |
|
|||||
|
2024
Q3 | $1.28M | Buy |
|
|||||
|
2024
Q2 | $165K | Buy |
|
|||||
|
2024
Q1 | $132K | Sell |
|
|||||
|
2023
Q4 | $714K | Buy |
|
|||||
|
2023
Q3 | $20.3K | Sell |
|
|||||
|
2023
Q2 | $40.3K | Sell |
|
|||||
|
2023
Q1 | $41.6K | Buy |
|
|||||
|
2022
Q4 | $27.4K | Sell |
|
|||||
|
2022
Q3 | $70K | Buy |
|
|||||
|
2022
Q2 | $69K | Sell |
|
|||||
|
2022
Q1 | $135K | Buy |
|
|||||
|
2021
Q4 | $64K | Sell |
|
|||||
|
2021
Q3 | $59K | Sell |
|
|||||
|
2021
Q2 | $148K | Buy |
|
|||||
|
2021
Q1 | $169K | Buy |
|
|||||
|
2020
Q4 | $90K | Sell |
|
|||||
|
2020
Q3 | $107K | Sell |
|
|||||
|
2020
Q2 | $472K | Sell |
|
|||||
|
2020
Q1 | $832K | Sell |
|
|||||
|
2019
Q4 | $5.96M | Sell |
|
|||||
|
2019
Q3 | $6.53M | Sell |
|
|||||
|
2019
Q2 | $14.5M | Sell |
|
|||||
|
2019
Q1 | $35.1M | Sell |
|
|||||
|
2018
Q4 | $46M | Sell |
|
|||||
|
2018
Q3 | $147M | Buy |
|
|||||
|
2018
Q2 | $91.3M | Buy |
|
|||||
|
2018
Q1 | $70.5M | Sell |
|
|||||
|
2017
Q4 | $58.9M | Sell |
|
|||||
|
2017
Q3 | $72.4M | Buy |
|
|||||
|
2017
Q2 | $48.7M | Sell |
|
|||||
|
2017
Q1 | $44.9M | Sell |
|
|||||
|
2016
Q4 | $49.4M | Sell |
|
|||||
|
2016
Q3 | $98M | Sell |
|
|||||
|
2016
Q2 | $126M | Buy |
|
|||||
|
2016
Q1 | $104M | Sell |
|
|||||
|
2015
Q4 | $120M | Buy |
|
|||||
|
2015
Q3 | $89.1M | Buy |
|
|||||
|
2015
Q2 | $103M | Buy |
|
|||||
|
2015
Q1 | $78.3M | Buy |
|
|||||
|
2014
Q4 | $50.5M | Sell |
|
|||||
|
2014
Q3 | $66.4M | Sell |
|
|||||
|
2014
Q2 | $107M | Buy |
|
|||||
|
2014
Q1 | $112M | Hold |
|
|||||
|
2013
Q4 | $87.6M | Hold |
|
|||||
|
2013
Q3 | $72.1M | Buy |
|
|||||
|
2013
Q2 | $45.7M | Buy |
|